Relationship between driver gene mutation status in non-small cell lung cancer and the incidence of venous thromboembolism: a Meta-analysis
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 2
Abstract
Objective：To systematically review the incidence of venous thromboembolism (VTE) in patients with non-small-cell lung cancer (NSCLC) by different driver gene mutations, and to further explore the associations of driver gene mutation status with the risk of VTE in patients with NSCLC.Methods： A complete search of PubMed, EMbase, Web of Science, Cochrane Library, CNKI, Wanfang and VIP Database were performed to obtain eligible studies on the relationship between driver gene mutation status and the risk of VTE published to 3rd July 2023. Statistical analysis was performed using Stata 14.0 software. Results： A total of 32 studies were included, with an overall sample size of 18 032 cases. The meta-analysis Results： indicated that the overall incidence of VTE in lung cancer patients with driver gene mutations was 19%［95%CI(15%-23%)］;the incidence of VTE complications was highest at 31%［95%CI(22%-39%)］ in patients with ROS1 gene fusion. The presence of anaplastic lymphoma kinase (ALK)/ROS1 gene fusion/rearrangement and positive programmed death-ligand 1 (PD-L1) expression was associated with an increased risk of VTE ［ALK: OR=2.28,95%CI(1.89-2.76); ROS1: OR=3.18,95%CI(1.89-5.35); PD-L1: OR=1.85,95%CI (1.25-2.72)］, while epidermal growth factor receptor（EGFR）/kirsten rat sarcoma viral oncogene (KRAS) gene mutations showed no significant correlation with the risk of VTE ［EGFR:OR=1.16,95%CI(0.75-1.80); KRAS: OR=1.54,95%CI(0.98-2.43)］. Conclusion：There are significant differences in the incidence of VTE complications related to NSCLC under different driver gene mutation statuses. The presence of ALK/ROS1 gene fusion/rearrangement and positive PD-L1 expression is associated with an increased risk of VTE, whereas EGFR/KRAS gene mutations do not show a significant correlation with VTE risk.
Authors and Affiliations
LI Huimin,TIAN Yu, LI Hong, LI Yulu, LUO Qin
Keywords
Related Articles
- EP ID EP759943
- DOI 10.13429/j.cnki.cjcr.2025.02.011
- Views 30
- Downloads 0
Application of predictive nursing in chemotherapy nursing of lung cancer based on risk management theory
Objective To explore the application value of predictive nursing based on risk management theory in nursing of lung cancer patients undergoing chemotherapy. Methods Ninety-eight lung cancer patients receiving chemotherap...
Mechanism of human leukocyte antigen-G inhibiting T cell immune function in triple-negative breast cancer
"<b>Objective</b>To investigate the mechanism of human leukocyte antigen-G (HLA-G) expression and T cells activation in triple-negative breast cancer(TNBC) cells to exert immunosuppressive function. <b>Methods</b> From...
Risk factors, pathogenic bacteria and drug sensitivities of pancreatic fistula combined with abdominal infection after pancreaticoduodenectomy
Objective To investigate the risk factors for pancreatic fistula combined with abdominal infection after pancreaticoduodenectomy, and to analyze the composition of pathogens and their drug sensitivity. Methods A retros...
Advances in vasculogenic mimicry in breast cancer
Vasculogenic mimicry (VM) is a blood vessel-like structure formed by tumor cells and extracellular matrix, which can mimic the function of blood vessels while providing nutrients to tumors. Tumor angiogenesis plays an im...
Two types of anterior cervical fusion for the treatment of two-segment cervical spondylotic myelopathy: clinical efficacy and imaging analysis
<b>Objective</b> To compare the effectiveness of anterior cervical discectomy and fusion (ACDF) and anterior cervical corpectomy and fusion (ACCF) in the treatment of twolevel cervical spondylotic myelopathy. <b>Method...